• Muscarinic M1 Receptor Drives Docetaxel Resistance in Prosta

  2026-04-23

  Wang et al. reveal that cholinergic muscarinic M1 receptor (CHRM1) activation underlies acquired resistance to docetaxel in castration-resistant prostate cancer (CRPC). The study uncovers a CHRM1–cMET interaction that orchestrates a MAPK-driven polykinase program, suggesting that CHRM1 inhibition can restore docetaxel sensitivity and highlighting a new therapeutic target in advanced prostate malignancy.

• Azathramycin A (BA1060): Reliable Macrolide for Tuberculosis

  2026-04-22

  This article addresses real-life laboratory challenges in cell viability and tuberculosis research, demonstrating how Azathramycin A (SKU BA1060) offers reproducible, data-backed solutions as a macrolide antibiotic. Scenario-driven Q&As highlight evidence-based strategies for assay optimization, protocol design, and product selection, positioning Azathramycin A as a robust tool for Mycobacterium tuberculosis research.

• AZD0156: ATM Kinase Inhibitor for High-Fidelity DNA Repair A

  2026-04-22

  AZD0156 empowers researchers to precisely inhibit ATM kinase, enabling robust analysis of DNA double-strand break repair and checkpoint control in advanced cancer models. Its exceptional selectivity and bioavailability streamline combinatorial workflows and enhance assay reproducibility, making it a standout choice for translational and preclinical studies.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Models

  2026-04-21

  Azathramycin A unlocks high-specificity, reproducible protein synthesis inhibition for tuberculosis model systems. Explore optimized protocols, troubleshooting strategies, and advanced applications that set this macrolide antibiotic apart for antibacterial and resistance research.

• Pazopanib Hydrochloride: Mechanistic Depth for Translational

  2026-04-21

  This thought-leadership article provides translational researchers with a mechanistic roadmap for leveraging Pazopanib Hydrochloride (GW786034) in advanced oncology research. By integrating rigorous in vitro evaluation strategies, competitive intelligence, and clinical context, we deliver actionable protocols and strategic guidance. APExBIO’s proven commitment to product excellence and workflow optimization is highlighted throughout, positioning Pazopanib Hydrochloride as a cornerstone for innovation in anti-angiogenic cancer research.

• GLP-1 (9-36) amide: Human GLP-1 Receptor Antagonist for Rese

  2026-04-20

  GLP-1 (9-36) amide is a rigorously validated glucagon-like peptide-1 receptor antagonist, essential in dissecting GLP-1 receptor signaling. Its defined molecular profile and robust quality controls make it a gold-standard tool for metabolic regulation and type 2 diabetes research.

• Efficacy and Safety of Azilsartan Medoxomil in Hypertension:

  2026-04-20

  A 2024 meta-analysis systematically evaluates azilsartan medoxomil's (TAK 491) efficacy and safety in lowering blood pressure among hypertensive and diabetic populations. The findings reveal significant blood pressure reductions with no significant increase in adverse events, positioning this ARB as a robust candidate for essential hypertension treatment research.

• JZL184: Selective MAGL Inhibitor for Endocannabinoid Researc

  2026-04-19

  JZL184 is a highly selective monoacylglycerol lipase inhibitor used to modulate endocannabinoid signaling in preclinical models. It elevates 2-AG levels, enabling detailed study of CB1 receptor-mediated pathways, particularly in neuropharmacology and pain research. APExBIO provides JZL184 (SKU B1958) at >98% purity for robust and reproducible results.

• Native Protein Gel Electrophoresis: Functional Proteomics wi

  2026-04-18

  Explore how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit enables advanced, activity-preserving native protein gel electrophoresis for acidic proteins. This article delivers a mechanistic and translational perspective, uniquely bridging assay design with insights from recent cancer research.

• Diagnosis and Topical Management of Cutaneous Candidiasis: G

  2026-04-17

  This article reviews the Japanese medical mycology guidelines for the diagnosis and topical treatment of cutaneous and oral candidiasis. It highlights the central role of imidazole antifungals, such as Neticonazole Hydrochloride, and emphasizes evidence-based diagnostic protocols and efficacy outcomes, offering critical insights for translational and clinical researchers.

• Troxerutin Inhibits TRPM7-Mediated Mitochondrial Fission in

  2026-04-16

  Li et al. reveal that troxerutin improves diabetic cognitive dysfunction (DCD) by inhibiting mitochondrial fission through the TRPM7/calcineurin/Drp1ser637 pathway. This mechanistic insight identifies TRPM7 as a potential target for intervention in DCD and highlights the therapeutic promise of troxerutin for neuroprotection in diabetic contexts.

• TCEP Hydrochloride: Transforming Sensitivity in Capture-and-

  2026-04-15

  Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein workflow precision. This article blends mechanistic insight with strategic guidance, highlighting breakthrough findings in sensitivity-enhanced lateral flow assays and capture-and-release strategies. Learn how APExBIO's high-purity TCEP hydrochloride sets new standards for translational research, bridging bench innovation with clinical impact.

• AZ505: SMYD2 Inhibitor Powering Epigenetic and Fibrosis Rese

  2026-04-14

  AZ505, a potent and selective SMYD2 inhibitor, is transforming experimental pipelines in epigenetic regulation and disease modeling. Its nanomolar potency and substrate-competitive mechanism deliver reproducible inhibition of SMYD2, opening new avenues in cancer biology and renal fibrosis research.

• Reelin-SFK Signaling is Essential for Ketamine’s Antidepress

  2026-04-13

  This study demonstrates that intact synaptic Reelin signaling and Src family kinase (SFK) activity are critical for ketamine-induced synaptic plasticity and behavioral antidepressant effects in mice. The findings elucidate a mechanistic barrier to ketamine efficacy in treatment-resistant depression and provide a research framework for dissecting antidepressant signaling pathways.

• Indomethacin in Translational Research: Bridging Inflammatio

  2026-04-13

  This thought-leadership article empowers translational researchers to harness Indomethacin—an NSAID with Cox-1 selectivity and PPARγ agonist activity—not only for inflammation models, but also for advanced studies in adipocyte differentiation, lipid metabolism, and membrane signaling. By integrating recent mechanistic insights, including the role of SEMA3E in beige adipocyte thermogenesis, and cross-referencing peer-validated workflows, the article delivers strategic guidance for experimental design, product selection, and translational outcomes. The discussion is anchored by APExBIO’s high-purity Indomethacin (A8449), articulating how this resource supports cutting-edge inquiry beyond conventional NSAID use.

14406 records 1/961 page Next 12345 下5页 Last page